受国际知名专业机构汤森路透（Thomson Reuters）邀请，环球律师事务所首次为其撰写“Commercialisation of Healthcare Global Guide 2021, China Chapter”，作为其“全球法律实务指南系列”的一部分。汤森路透致力于为全球律师提供一流的法律实务知识，对于每个法律实务指南，汤森路透都会邀请在该领域广受认可的法律人士撰稿。（请点击文末“相关下载”下载“Commercialisation of Healthcare Global Guide 2021, China Chapter”全文）

Global Law Office was invited by Thomson Reuters, one of the most authoritative international agencies, to contribute to the China Chapter for the Commercialization of Healthcare Global Guide 2021 for the first time, which is a part of Thomson Reuters Global Guide Practical Law Series. Thomson Reuters is committed to providing first-class legal practice knowledge for lawyers around the world. For each Practical Law, it will invite legal professionals who are widely recognized in their field to write articles. (Please download the guide by clicking the button “Download/相关下载” at the end of this article)

本次的撰文中，环球律师事务所周磊、黄旭春、何璇以Q&A形式，对在中国大陆地区的医药健康产品的监管框架进行了系统性的梳理，从实务角度对药品、生物药品、医疗器械、其他医药健康产品和天然健康产品的制造、营销和广告的等方面进行了全面的介绍和解读，旨在提供全面、系统、权威的中国医药健康商业化实践法律实务指南。如果您希望就本指南或者与本指南讨论的内容进一步交流，敬请联系撰文作者。

This Chapeter is drafted by Alan Zhou, Charlene Huang as well as Samantha He. From a form of Q&A, it provides an overview of the regulatory framework for the commercialisation of medical products in China. It covers the key requirements for manufacturing, marketing, and advertising medicines, biological medicines, medical devices, combination products, and natural health products which aims to provide comprehensive guidelines of Commercialization of Healthcare. If you have any inquiries or comments about the publication or related issues, please feel free to contact the authors.

关于汤森路透

汤森路透（Thomson Reuters）是全球领先的商务和专业信息供应商，其法律事业部拥有众多世界知名的法律产品，其中Practical Law品牌历史已超过二十年，致力于通过庞大实用的数据库，为全球律师提供一流的法律实务知识。为保障数据库内容的国际一流水准，应邀负责撰写相关章节内容的均为该领域的国际知名资深律师。